Year Ended
|
||||||||
October 31,
2023
|
October 31,
2022
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
199,634
|
$
|
179,242
|
||||
Adjustments to reconcile net income to net cash
|
||||||||
provided by operating activities:
|
||||||||
Depreciation and amortization
|
80,835
|
80,330
|
||||||
Share-based compensation
|
8,001
|
6,308
|
||||||
Changes in operating assets, liabilities and other
|
13,706
|
9,307
|
||||||
Net cash provided by operating activities
|
302,176
|
275,187
|
||||||
Cash flows from investing activities:
|
||||||||
Purchases of property, plant and equipment
|
(131,295
|
)
|
(112,338
|
)
|
||||
Purchases of available-for-sale debt securities
|
(20,192
|
)
|
(38,854
|
)
|
||||
Proceeds from maturity of available-for-sale debt securities
|
47,537
|
-
|
||||||
Government incentives
|
2,522
|
3,615
|
||||||
Other
|
(117
|
)
|
(180
|
)
|
||||
Net cash used in investing activities
|
(101,545
|
)
|
(147,757
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayments of debt
|
(18,439
|
)
|
(65,440
|
)
|
||||
Purchases of treasury stock
|
-
|
(2,522
|
)
|
|||||
Contributions from noncontrolling interest
|
-
|
24,995
|
||||||
Proceeds from share-based arrangements
|
1,248
|
5,749
|
||||||
Net settlements of restricted stock awards
|
(1,302
|
)
|
(1,471
|
)
|
||||
Net cash used in financing activities
|
(18,493
|
)
|
(38,689
|
)
|
||||
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
|
(2,680
|
)
|
(46,012
|
)
|
||||
Net increase in cash, cash equivalents, and restricted cash
|
179,458
|
42,729
|
||||||
Cash, cash equivalents, and restricted cash, beginning of period
|
322,409
|
279,680
|
||||||
Cash, cash equivalents, and restricted cash, end of period
|
$
|
501,867
|
$
|
322,409
|